Cipla Appoints Shivam Puri as CEO of One India Business

IMT News Desk
IMT News Desk
· 1 min read
Cipla appoints Shivam Puri as CEO of One India Business, effective July 1, 2026. Puri brings 23+ years of FMCG & healthcare experience

Cipla has appointed Mr. Shivam Puri as the Chief Executive Officer of One India Business and a member of the Management Council, effective July 1, 2026, bringing over 23 years of leadership experience across both FMCG and healthcare sectors to the role.

Mr. Puri concurrently serves as the Managing Director and Chief Executive Officer of Cipla Health Limited, the company’s wholly owned subsidiary focused on consumer healthcare and wellness products, and will continue to lead Cipla Health while taking on the additional responsibility of CEO-One India Business.

Mr. Puri brings expertise in driving innovation, market expansion and operational efficiency to the One India Business, with Cipla Health being amongst the largest OTC/FMWG (Fast Moving Wellness Goods) companies in India and growing rapidly in multiple global markets.

With the appointment, Cipla signals its commitment to strengthening its domestic pharma portfolio while maintaining focus on consumer healthcare growth, leveraging Mr. Puri’s extensive experience in building brands and scaling operations across regulated and non-regulated healthcare segments.

The One India Business represents Cipla’s strategic focus on consolidating its presence in the Indian pharmaceutical market, with Mr. Puri’s dual role expected to create synergies between the company’s pharmaceutical and consumer healthcare operations.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk